Skip to content

Growth of Infants Fed Hydrolysate Formulas

Growth of Infants Fed Hydrolysate Formulas

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02006992
Enrollment
195
Registered
2013-12-10
Start date
2000-03-31
Completion date
2000-11-30
Last updated
2013-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Growth and Tolerance

Brief summary

Effects on weight and weight gain will be monitored in healthy term infants fed assigned infant formulas.

Interventions

OTHERRTF Infant Formula

a RTF extensively hydrolyzed infant formula

OTHERPowder Infant Formula

a powdered extensively hydrolyzed infant formula.

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 9 Days
Healthy volunteers
Yes

Inclusion criteria

* Infants in good health. * Singleton, term birth with a gestational age of 37 to 42 weeks. * Birth weight of 2500 g (5 lb 8 oz) or greater. * Between 0 and 9 days of age at enrollment. * Not receiving vitamin or mineral supplements.

Exclusion criteria

\- Maternal, fetal or perinatal medical history with potential for adverse effects on growth or development.

Design outcomes

Primary

MeasureTime frame
WeightStudy day 1 to 112 days of age

Secondary

MeasureTime frame
LengthStudy day 1 to 112 days of age
Head CircumferenceStudy day 1 to 112 days of age
Study Formula IntakeEnrollment to 112 days of age
Incidence of Spit UpEnrollment to 112 days of age
Stool PatternEnrollment to 112 days of age

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026